Published in Trends Cancer on January 27, 2017
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A (1995) 24.77
Enhancement of antitumor immunity by CTLA-4 blockade. Science (1996) 17.94
Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell (2009) 14.40
Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 10.04
Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell (2013) 8.37
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science (2001) 8.31
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov (2011) 7.65
Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell (2012) 5.53
Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell (2012) 4.51
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature (2015) 4.18
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature (2015) 3.77
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature (2015) 3.24
Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer (2007) 3.17
The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development (2001) 3.14
Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res (2003) 3.13
Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development (2007) 3.07
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. N Engl J Med (2015) 3.00
Collective chemotaxis requires contact-dependent cell polarity. Dev Cell (2010) 2.95
Classifying collective cancer cell invasion. Nat Cell Biol (2012) 2.83
Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature (2014) 2.71
In situ identification of bipotent stem cells in the mammary gland. Nature (2014) 2.71
DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell (2012) 2.66
Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest (2009) 2.55
Collective invasion in breast cancer requires a conserved basal epithelial program. Cell (2013) 2.51
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. Cancer Cell (2010) 2.50
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain (2010) 2.49
HIF induces human embryonic stem cell markers in cancer cells. Cancer Res (2011) 2.46
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell (2014) 2.40
The longest telomeres: a general signature of adult stem cell compartments. Genes Dev (2008) 2.38
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nat Med (2016) 2.27
The role of hypoxia in development of the Mammalian embryo. Dev Cell (2009) 2.12
Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res (2012) 2.12
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis. N Engl J Med (2015) 2.08
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol (2015) 2.02
Molecular basis of cell migration in the fish lateral line: role of the chemokine receptor CXCR4 and of its ligand, SDF1. Proc Natl Acad Sci U S A (2002) 2.01
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res (2002) 1.93
Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology (2012) 1.91
Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol (2010) 1.89
Independent regulation of tumor cell migration by matrix stiffness and confinement. Proc Natl Acad Sci U S A (2012) 1.89
Keeping in touch with contact inhibition of locomotion. Trends Cell Biol (2010) 1.85
HIF activation by pH-dependent nucleolar sequestration of VHL. Nat Cell Biol (2004) 1.79
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. J Clin Oncol (2015) 1.72
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med (2016) 1.69
Targeting renal cell carcinoma with a HIF-2 antagonist. Nature (2016) 1.68
Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci U S A (2006) 1.67
Adaptive Immune Regulation of Mammary Postnatal Organogenesis. Dev Cell (2015) 1.48
The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clin Cancer Res (2008) 1.28
Tension-oriented cell divisions limit anisotropic tissue tension in epithelial spreading during zebrafish epiboly. Nat Cell Biol (2013) 1.18
Hypoxic control of metastasis. Science (2016) 1.16
Analysing collisions between fibroblasts and fibrosarcoma cells: fibrosarcoma cells show an active invasionary response. J Cell Sci (1986) 1.16
Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development (2011) 1.13
Luminal cells are favored as the cell of origin for prostate cancer. Cell Rep (2014) 1.12
A link between PDL1 and T regulatory cells in fetomaternal tolerance. J Immunol (2007) 1.12
The front and rear of collective cell migration. Nat Rev Mol Cell Biol (2016) 1.12
Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci U S A (2011) 1.11
NUT midline carcinoma. Nat Rev Cancer (2014) 1.11
Cell biology of disease: Telomeropathies: an emerging spectrum disorder. J Cell Biol (2014) 1.07
Wnt5a directs polarized calcium gradients by recruiting cortical endoplasmic reticulum to the cell trailing edge. Dev Cell (2013) 1.07
Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors. Cancer Res (2012) 1.06
A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer. Ann Oncol (2014) 1.06
Avian neural crest cells can migrate in the dorsolateral path only if they are specified as melanocytes. Development (1995) 1.04
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy. Cell Stem Cell (2014) 1.04
Defining the cellular lineage hierarchy in the interfollicular epidermis of adult skin. Nat Cell Biol (2016) 0.96
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family. Immunity (2016) 0.96
HIF1α Represses Cell Stress Pathways to Allow Proliferation of Hypoxic Fetal Cardiomyocytes. Dev Cell (2015) 0.91
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity (2016) 0.88
Chromatin modifiers and the promise of epigenetic therapy in acute leukemia. Leukemia (2014) 0.86
A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells. Cell Cycle (2014) 0.86
ECM Signaling Regulates Collective Cellular Dynamics to Control Pancreas Branching Morphogenesis. Cell Rep (2015) 0.85
Activation of Wnt signalling promotes development of dysplasia in Barrett's oesophagus. J Pathol (2012) 0.85
Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease. Trends Cell Biol (2016) 0.83
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships. Mol Oncol (2015) 0.80
Regulation of costimulatory signal in maternal-fetal immune tolerance. Am J Reprod Immunol (2011) 0.79
A 3D tension bioreactor platform to study the interplay between ECM stiffness and tumor phenotype. J Biotechnol (2014) 0.79
Emerging concepts of epigenetic dysregulation in hematological malignancies. Nat Immunol (2016) 0.79
Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial. Liver Int (2016) 0.79
Ipilimumab Combined with Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma? Clin Cancer Res (2016) 0.78
A Long-Lived Luminal Subpopulation Enriched with Alveolar Progenitors Serves as Cellular Origin of Heterogeneous Mammary Tumors. Stem Cell Reports (2015) 0.77
Intratumoral oxygen gradients mediate sarcoma cell invasion. Proc Natl Acad Sci U S A (2016) 0.76
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma. Oncologist (2017) 0.76
Hypoxia promotes production of neural crest cells in the embryonic head. Development (2016) 0.76
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma. Oncologist (2017) 0.76
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study. J Neurooncol (2016) 0.75
Current management of newly diagnosed acute promyelocytic leukemia. Ann Oncol (2016) 0.75